irinotecan has been researched along with Abnormalities, Autosome in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Brčić Karačonji, I; Jurič, A; Kopjar, N | 1 |
Gamulin, M; Kasuba, V; Rozgaj, R; Trosić, I | 1 |
Attia, S | 1 |
Berend, S; Fuchs, N; Kopjar, N; Radić, B; Vrdoljak, AL; Zeljezić, D | 1 |
Kojima, A; Saijo, N; Shinkai, T | 1 |
5 other study(ies) available for irinotecan and Abnormalities, Autosome
Article | Year |
---|---|
Homogentisic acid, a main phenolic constituent of strawberry tree honey, protects human peripheral blood lymphocytes against irinotecan-induced cytogenetic damage in vitro.
Topics: Chromosome Aberrations; Homogentisic Acid; Humans; In Vitro Techniques; Irinotecan; Lymphocytes; Topoisomerase I Inhibitors | 2021 |
Assessment of cyto/genotoxicity of irinotecan in v79 cells using the comet, micronucleus, and chromosome aberration assay.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Cells, Cultured; Chromosome Aberrations; Comet Assay; Cricetinae; Cricetulus; Irinotecan; Micronucleus Tests; Mutagenicity Tests | 2010 |
Modulation of irinotecan-induced genomic DNA damage by theanine.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chromosome Aberrations; DNA Damage; Dose-Response Relationship, Drug; Glutamates; Irinotecan; Male; Mice; Micronucleus Tests; Oxidative Stress | 2012 |
Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its cyto/genotoxicity in vitro.
Topics: Acetylcholinesterase; Adult; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cells, Cultured; Cholinesterase Inhibitors; Chromosome Aberrations; Female; Humans; Irinotecan; Lymphocytes; Molecular Structure; Oximes; Pyridinium Compounds | 2007 |
Cytogenetic effects of CPT-11 and its active metabolite, SN-38 on human lymphocytes.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Chromosome Aberrations; Dose-Response Relationship, Drug; Humans; Irinotecan; Lymphocytes; Mutagens; Neoplasms; Sister Chromatid Exchange; Time Factors | 1993 |